CME Group (CME) PT Raised to $300 at TD Cowen on 'Broadening Growth Drivers'
TD Cowen analyst Bill Katz raised the price target on CME Group (NASDAQ: CME) to $300.00 (from $292.00) while maintaining a Buy rating.
The analyst commented: "Broadening Growth Drivers - Management Meeting Takes; We affirm our Buy rating, raise our '26-27E adj. EPS and lift our 12M price target $8 to $300 post TD Cowen-sponsored investor meetings with senior management, truing up for 3Q ADV/ stronger outlook and higher repurchase. Concurrently, we lift our preference on CME among our Exchanges ranks.
Affirm Buy; lift 12M price target $8 to $300, reflecting higher earnings expectations. We move CME up our relative ranks w/in Exchanges."